PetCaseFinder

Peer-reviewed veterinary case report

Mule with eye problems and nerve disease from Neospora hughesi

By Finno, Carrie J et al.·Published in Veterinary ophthalmology·2010·William R. Pritchard Veterinary Medical Teaching Hospital, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Equine protozoal myeloencephalitis due to Neospora hughesi and equine motor neuron disease in a mule.

Species:
horse

Plain-English summary

A 23-year-old female mule was brought in for eye problems and an unusual way of walking. The vet found several issues, including differences in pupil size, facial nerve paralysis, and muscle wasting. Tests showed she had equine protozoal myeloencephalitis (EPM) caused by Neospora hughesi and equine motor neuron disease (EMND). She was treated with a medication called ponazuril, along with vitamin E and selenium for two months, but while she didn't get worse, she also didn't show improvement. After stopping the ponazuril, her condition worsened.

People also search for: mule eye problems · equine protozoal myeloencephalitis treatment · mule abnormal gait causes

Abstract

CASE DESCRIPTION: A 23-year-old female mule was presented for bilateral ocular abnormalities and an abnormal pelvic limb gait. CLINICAL FINDINGS: Anisocoria, unilateral enophthalmos, medial strabismus, ptosis, pupillary light reflex deficits, and bilateral reticulated pigmentary retinopathy were observed on ophthalmic examination. Neurologic abnormalities included right-sided facial nerve paralysis, extensive symmetric muscle atrophy, and asymmetric pelvic limb ataxia with an abnormal pelvic limb gait. A positive titer (1:40) for equine protozoal myeloencephalitis (EPM) associated with Neospora hughesi was obtained from cerebrospinal fluid with minimal (<1 red blood cell/microL) blood contamination. Muscle biopsies of the sacrocaudalis dorsalis medialis muscle revealed predominantly type I neurogenic muscle atrophy, consistent with a diagnosis of equine motor neuron disease (EMND). TREATMENT AND OUTCOME: Treatment included a 2-month course of ponazuril (5 mg/kg PO q24 h), vitamin E (8000 IU PO q24 h), and selenium (2 mg PO q24 h). Clinical improvement was not observed after 2 months although the mule remained stable. Clinical deterioration was reported upon discontinuation of the ponazuril after a 2-month course. CONCLUSION: Concurrent disease with EPM associated with N. hughesi and EMND should be considered in cases demonstrating cranial nerve abnormalities, pronounced symmetric muscle atrophy, unusual asymmetric gait abnormalities, and reticulated pigmentary retinopathy.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/20618805/